Bioversys AG (BIOV) — Cash Flow-to-Debt Ratio
Bioversys AG (BIOV) has a Cash Flow-to-Debt Ratio of -0.71x as of December 2025, meaning its operating cash flow of CHF-21.95 Million could theoretically repay -1% of its total liabilities (CHF30.82 Million) in one year. See Bioversys AG working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bioversys AG Cash Flow-to-Debt Ratio (2024–2025)
Historical debt coverage capacity for Bioversys AG across 2 annual periods. Also explore Bioversys AG equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bioversys AG (2024–2025)
Year-by-year debt coverage analysis for Bioversys AG. For market capitalisation and broader financial context, see Bioversys AG (BIOV) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.71x | CHF-21.95 Million | CHF30.82 Million | ▼ -11.0% |
| 2024 | -0.64x | CHF-15.57 Million | CHF24.27 Million | — |